Energy

Marathon Oil Meets Profit Estimates, Beats on Revenues

Thinkstock

Marathon Oil Corp. (NYSE: MRO) reported fourth-quarter and full-year 2015 results after markets closed Wednesday. For the quarter, the oil & gas production company posted an adjusted diluted net loss per share of $0.48 on revenues of $1.48 billion. In the same period a year ago, the company reported a break-even quarter on revenues of $2.5 billion. Fourth-quarter results compare to the Thomson Reuters consensus estimates for a net loss of $0.48 on revenues of $1.17 billion.
For the year Conoco posted an adjusted net loss of $1.28 per share and revenues of $5.86 billion. In 2014 the company posted earnings per share of $2.53 and revenues of $11.26 billion. Analysts were expecting a net loss of $1.29 and revenues of $5.61 billion.

On a GAAP basis the quarterly loss per share totaled $1.17 and the full-year loss per share totaled $3.26.

In 2015 Marathon added proved reserves of 247 million barrels of oil equivalent, an organic replacement level of 157% with a finding and development cost of $12 per barrel. Including revisions and excluding dispositions, the reserve replace ration was 89%. The company’s net proved reserves totaled about 2.2 billion barrels of oil equivalent at the end of 2015.

The company reported $3 billion in capital spending for 2015, about $500 million below its prior estimate.

Marathon did not provide quarterly and fiscal year 2016 guidance in its press release, but analysts are look for a first quarter net loss of $0.52 per share and a full-year net loss of $1.55 per share. Revenue is forecast at $965.2 million for the quarter and $4.75 billion for the year.

CEO Lee Tillman said:

In the fourth quarter, our capital spend and production costs both came in better than expectations. Operational results were supported by a more than 20 percent increase in Oklahoma unconventional volumes while maintaining flat production levels in the Eagle Ford. More recently, we reached a major milestone in Equatorial Guinea with the successful installation of the jacket and topsides for the Alba field compression project, on schedule to start up by mid-year 2016.

Marathon’s shares traded up about 1.5% in Wednesday’s after-hour session at $7.52 in a 52-week range of $6.52 to $31.53. Thomson Reuters had a consensus analyst price target of $15.21 before today’s report.

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.